Author

Sydney Abelson

University of California, San FranciscoORCID 0009-0003-0883-4165Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Research Focus:perturbation response prediction· 2 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Catherine Choy SmithiD· 2 shared Elliot StieglitziD· 2 shared José M. RiveraiD· 2 shared Aaron C. LoganiD· 1 shared Aishwarya C. Ballapuram· 1 shared Andrew Koh· 1 shared Benjamin F. CravattiD· 1 shared Benjamin J. HuangiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Catherine Choy SmithORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintJun 10, 2025

Multi-selective RAS(ON) Inhibition Targets Oncogenic RAS Mutations and Overcomes RAS/MAPK-Mediated Resistance to FLT3 and BCL2 Inhibitors in Acute Myeloid Leukemia

Bogdan Popescu, Matthew F. Jones, Madison Piao…·Catherine Choy Smith

This study evaluates RMC-7977, a RAS(ON) inhibitor, showing efficacy against RAS-driven resistance in AML and potential for combination therapies.

3 citations

humanexperimental assay

𝕏 PostBluesky

Cancer BiologybioRxivPreprintMar 20, 2025

In vivo validation of the palmitoylation cycle as a therapeutic target in NRAS-mutant cancer

Matthew Decker, Benjamin J. Huang, Timothy B. Ware…·Kevin Shannon

This study validates the palmitoylation cycle as a therapeutic target in NRAS-mutant cancers by showing that inhibiting ABHD17 reduces tumor growth and synergizes with MEK inhibitors.

3 citations

mouseexperimental assay

𝕏 PostBluesky